Active Pharmaceutical Ingredients

PHARMACEUTICAL

At AntalGenics we develop novel therapeutic leads, mainly for the treatment of psoriatic pruritus and psoriatic comorbidities, such as arthritis

PHARMACEUTICAL

Our R&D programme is focused on the discovery and development of new molecules to treat chronic painful disorders. Our scientific team has a long-track experience in pain research. With this knowledge, we are currently developing two new molecular entities to provide precise innovative therapies for psoriatic pruritus and osteoarthritic pain

ANTALGENICS OFFERS

Proven-track record in pain research
Specialists in ion channel research and neuronal exocytosis
Full access to University infrastructures
Skilled team in sensory biology
Rich-network of partner research groups
Experts in molecular modeling and in silico screening
A long standing experience in cosmeceutics

Now that you are here, take a look at our cosmetic ingredients

Privacy Policy
AntalGenics_logo_7

This website uses own and third party cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful. More information about our Privacy Policy

Own cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

Third party cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.